Please enable JavaScript or talk to your local administrator to get JavaScript enabled.

Funder

NCI National Cancer Institute

United States

 
301
Projects
USD 249.0 M
Aggregated funding amount
USD 827 K
Average funding amount
 
76
Researchers currently funded
Projects All >
Sorted by: Start Date
Project list item
Chromatin Modifier Gene Mutation and Enhancer Dysfunction in Bladder Cancer

National Cancer Institute to BYRON H LEE

USD 243,205
2019 - 2024
Project list item
Combatting Bladder Cancer by Inducing Epithelial Turnover

National Cancer Institute to SOMAN N ABRAHAM

USD 203,510
2019 - 2021
Project list item
Phase 1/2 Study of Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder - (ADAPT-BLADDER)

National Cancer Institute to NOAH M HAHN

USD 656,816
2019 - 2024
Project list item
Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma

National Cancer Institute to HIKMAT AL-AHMADIE

USD 410,835
2019 - 2024
Project list item
Development of an automated method to capture bladder cancer recurrence and progression for epidemiologic research

National Cancer Institute to KIM N DANFORTH

USD 172,270
2019 - 2021

Researchers

All >

Funding amount

Categories FOR (ANZSRC)

All >

Projects

  • 228

    1112 Oncology and Carcinogenesis

  • 37

    0601 Biochemistry and Cell Biology

  • 32

    0604 Genetics

  • 28

    1117 Public Health and Health Services

  • 26

    1107 Immunology

  • 18

    1103 Clinical Sciences

  • 6

    1115 Pharmacology and Pharmaceutical Sciences

  • 3

    0801 Artificial Intelligence and Image Processing

  • 3

    0903 Biomedical Engineering

  • 2

    0301 Analytical Chemistry

  • 1

    0104 Statistics

  • 1

    0605 Microbiology

  • 1

    1004 Medical Biotechnology

  • 1

    1114 Paediatrics and Reproductive Medicine

Categories RCDC

All >

Projects

  • 284

    Cancer

  • 282

    Urologic Diseases

  • 150

    Clinical Research

  • 113

    Genetics

  • 85

    Prevention

  • 73

    Biotechnology

  • 31

    Rare Diseases

  • 25

    Human Genome

  • 23

    Bioengineering

  • 22

    Clinical Trials and Supportive Activities

  • 21

    Tobacco

  • 20

    Complementary and Alternative Medicine

  • 20

    Smoking and Health

  • 17

    Immunization

  • 15

    Genetic Testing

  • 14

    Vaccine Related

  • 11

    Nutrition

  • 10

    Health Services

  • 9

    Aging

  • 8

    Diagnostic Radiology

Categories HRCS HC

All >

Projects

  • 274

    Cancer

  • 7

    Renal and Urogenital

  • 3

    Generic Health Relevance

  • 3

    Inflammatory and Immune System

  • 2

    Infection

  • 2

    Metabolic and Endocrine

Categories HRCS RAC

All >

Projects

  • 131

    2.1 Biological and endogenous factors

  • 42

    5.1 Pharmaceuticals

  • 34

    4.1 Discovery and preclinical testing of markers and technologies

  • 34

    4.2 Evaluation of markers and technologies

  • 8

    2.2 Factors relating to physical environment

  • 8

    6.1 Pharmaceuticals

  • 6

    5.2 Cellular and gene therapies

  • 5

    7.3 Management and decision making

  • 4

    3.3 Nutrition and chemoprevention

  • 3

    1.1 Normal biological development and functioning

  • 2

    6.5 Radiotherapy

  • 2

    7.1 Individual care needs

  • 1

    2.4 Surveillance and distribution

  • 1

    5.9 Resources and infrastructure (development of treatments)

  • 1

    8.1 Organisation and delivery of services

Categories Health Research Areas

All >

Projects

  • 213

    Biomedical

  • 45

    Clinical

  • 10

    Population & Society

  • 7

    Health services & systems

Categories Broad Research Areas

All >

Projects

  • 128

    Clinical Medicine and Science

  • 102

    Basic Science

  • 15

    Public Health

  • 4

    Health Services Research